Market Overview

US Stock Futures Signal Higher Start On Wall Street

Share:
US Stock Futures Signal Higher Start On Wall Street
Related NOK
Vetr Issues Strong Buy Rating On Nokia
20 Stocks Moving In Friday's Pre-Market Session
Nokia to publish third-quarter and January-September —…–7 interim report on October —6, ... (GuruFocus)
Related HAL
Baker Hughes, A Compelling Stock For The Conservative Investor
Benzinga's Option Alert Recap From October 18
Colorado Capital Management, Inc. Buys iShares International Select Dividend, Vanguard ... (GuruFocus)

Pre-open movers

US stock futures traded higher in early pre-market trade. The Chicago Fed National Activity Index for March will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average jumped 85.50 points to 17,855.50, while the Standard & Poor's 500 index futures rose 9.15 points to 2,084.65. Futures for the Nasdaq 100 index climbed 13.40 points to 4,362.40.

A Peek Into Global Markets

European markets were mostly higher today, with the Spanish Ibex Index dropping 0.45 percent, STOXX Europe 600 Index gaining 0.61 percent and German DAX 30 index gaining 1.48 percent. French CAC 40 Index climbed 0.30 percent and London's FTSE 100 Index rose 0.28 percent.

In Asian markets, Japan's Nikkei Stock Average fell 0.09 percent, China's Shanghai Composite Index dropped 2.02 percent, Hong Kong's Hang Seng Index fell 1.64 percent and India's BSE Sensex dipped 1.95 percent.

Broker Recommendation
Analysts at Jefferies downgraded Nokia Corporation (ADR) (NYSE: NOK) from Buy to Hold..

Nokia shares fell 0.52 percent to $7.58 in pre-market trading.

Breaking news

  • Halliburton Company (NYSE: HAL) reported upbeat results for the first quarter. To read the full news, click here.
  • Shares of Hasbro, Inc. (NYSE: HAS) jumped more than 7 percent in pre-market trading after the company reported stronger-than-expected earnings for the first quarter. To read the full news, click here.
  • Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today preclinical results that further support varlilumab's expansion into combination studies with PD-1 inhibitors. To read the full news, click here.
  • Morgan Stanley (NYSE: MS) reported stronger-than-expected results for the first quarter on Monday.To read the full news, click here.

Posted-In: Deutsche Bank US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

 

Related Articles (CLDX + HAL)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...